Abstract
Purpose of Review: To synthesize recent evidence relating the gut microbiome and microbial metabolites to cardiovascular disease (CVD) in people living with HIV (PLWH). Recent Findings: A few cross-sectional studies have reported on the gut microbiome and cardiovascular outcomes in the context of HIV, with no consistent patterns emerging. The largest such study found that gut Fusobacterium was associated with carotid artery plaque. More studies have evaluated microbial metabolite trimethylamine N-oxide with CVD risk in PLWH, but results were inconsistent, with recent prospective analyses showing null effects. Studies of other microbial metabolites are scarce. Microbial translocation biomarkers (e.g., lipopolysaccharide binding protein) have been related to incident CVD in PLWH. Summary: Microbial translocation may increase CVD risk in PLWH, but there is insufficient and/or inconsistent evidence regarding specific microbial species and microbial metabolites associated with cardiovascular outcomes in PLWH. Further research is needed in large prospective studies integrating the gut microbiome, microbial translocation, and microbial metabolites with cardiovascular outcomes in PLWH.
Original language | English (US) |
---|---|
Pages (from-to) | 86-99 |
Number of pages | 14 |
Journal | Current HIV/AIDS reports |
Volume | 20 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2023 |
Keywords
- Cardiovascular disease
- Gut microbiome
- HIV
- Metabolome
ASJC Scopus subject areas
- Virology
- Infectious Diseases